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Abstract:
Context of the Article: An important forensic problem is whether the 
presence of a drug such as morphine caused or contributed to a death or 
was merely incidental. The reliance that can be based on postmortem 
drug concentrations remains controversial. To investigate this further we 
obtained antemortem and postmortem samples of individuals admitted 
to hospital who were receiving morphine and who died in hospital. 
Methods: Eleven Subjects were recruited. Samples were sent for analysis 
of free and total morphine concentrations. Results: The median 
difference (postmortem - antemortem) free morphine concentration was 
25.5 (range 0 to +126) microg/L, P < 0.01; the mean difference 
between postmortem and antemortem total morphine concentration was 
34.5 (range -225 to 342) microg/L (not significant). Discussion: Our 
study supports previous investigators who note that there is an 
inconstant and sometimes tenuous relationship between ante- and 
postmortem morphine concentrations
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The relationship between antemortem and postmortem morphine concentrations
Abstract
Context of the Article: An important forensic problem is whether the presence of a drug such 
as morphine caused or contributed to a death or was merely incidental. The reliance that can 
be based on postmortem drug concentrations remains controversial. To investigate this 
further we obtained antemortem and postmortem samples of individuals admitted to hospital 
who were receiving morphine and who died in hospital. Methods: Eleven Subjects were 
recruited. Samples were sent for analysis of free and total morphine concentrations. Results: 
The median difference (postmortem - antemortem) free morphine concentration was 25.5 
(range 0 to +126) microg/L, P < 0.01; the mean difference between postmortem and 
antemortem total morphine concentration was 34.5 (range -225 to 342) microg/L (not 
significant). Discussion: Our study supports previous investigators who note that there is an 
inconstant and sometimes tenuous relationship between ante- and postmortem morphine 
concentrations
Key Words
Morphine, Postmortem examination, Postmortem redistribution, Forensic Toxicology
Introduction
Morphine is the standard treatment for severe pain. It is well absorbed orally and 
subcutaneously. It is eliminated mainly in the form of two major metabolites: inactive 
morphine-3-glucuronide and active morphine-6-glucuronide.[1] The glucuronides are 
excreted renally, and their elimination rates depend on age, renal function, and the route of 
administration. [2, 3] 
Opiate drugs, including morphine and heroin (diacetylmorphine, diamorphine) are also 
widely abused. The Office for National Statistics recorded 155 deaths during 1993 in England 
and Wales in which morphine or heroin or both were certified as the cause of death; by 2016 
the number had increased to 1209. [4] The total number of deaths certified from opioids rose 
from 444 to 1887 during the same period. 
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An important forensic problem is whether the presence of a drug such as morphine caused or 
contributed to a death or was merely incidental. Attempts to deduce the timing and likely 
impact of morphine or heroin ingestion from concentrations of total drug, free drug, 
metabolites, and their ratios, have proved difficult. [5, 6, 7] The relationship between the 
measured concentration postmortem and the likely concentration antemortem is not certain; 
and the degree to which the deceased was tolerant of the effects of the drug can greatly 
influence individual responses to a given concentration. 
The postmortem concentration of many drugs changes with time after death, and differs from 
one postmortem sampling site to another. [8, 9, 10, 11, 12]  Some have argued that ‘From our 
observations, significant postmortem redistribution of morphine and its metabolites seems 
unlikely.’[13]. Others have shown significant postmortem distribution in animal models [14, 
15] We sought to assess the relationship between antemortem and postmortem concentrations 
of morphine in paired samples tak n from patients before and after they died.
Methods
Ethics
The study received a favourable opinion from the National Research Ethics Services(IRAS 
192718) and was approved by the Health Research Authority.
Population
The study took place in a thousand-bedded teaching hospital caring for adults and children.
Sampling
Patients who died in hospital and who had been treated with morphine were identified. They 
were considered potentially suitable for the study if they had been treated with morphine, and 
a serum sample had been taken from them within 24 hours before they died and after the last 
administration of morphine. Consent to use samples for the study was obtained from the 
patient’s relatives. All subjects were transferred to the morgue within 8 hours and usually in 
less than 2 hours. The deceased were then stored at -4oC until postmortem sampling. Whole 
unpreserved blood samples were taken from the unligated femoral vein.
Toxicological Analysis
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Free morphine quantitation was performed after solid phase extraction by Bond Elut 
cartridges, using an Agilent® 1200 Series HPLC System fitted with an Agilent® ZORBAX 
SB-C18, 2.1mm ID x 30mm (3.5μm) column and Agilent® 6460 Triple Quadrupole LC-
MS/MS system with an electrospray ionisation (ESI) source in positive ion mode.  Total 
morphine concentration was measured after hydrolysis with β-glucuronidase at 70°C for 
3 hours. 
The assay is validated as per accepted forensic standards. The serum to whole blood ratio has 
been shown to be 1.03 (relative standard deviation 3.59%) [16, 17, 18] The limit of detection 
of the method was 1 g/L and the limit of quantitation was 5 g/L. The method was linear 
from 5–1000 g/L. The precision was < 7% and bias < 5%. There was no significant ion 
suppression from common drugs or from compounds produced during the postmortem 
period.   
Statistical analysis
We examined the data using descriptive statistics, and used Wilcoxon’s matched pairs 
signed-rank test to compare antemortem and postmortem concentrations.[19]
Results
Samples were obtained from 11 patients (six women), mean age 65 + 15 years, range 37–88 
years. Antemortem samples were taken a median of 5.75 hours (range 3-10) before death. The 
postmortem samples were taken a median of 6 days (range 3–12) after death. The demographic 
data, renal function, doses of opiates, routes of administration, are given in Table 1. 
Results for free and total morphine concentration before and after the patient had died are 
given in Table 2. For all subjects, free morphine concentrations were higher postmortem. The 
median difference between postmortem and antemortem free morphine concentrations was 
25.5g/L (range 0 to 126), P < 0.01. For all but one subject, total morphine concentrations 
were higher postmortem. The median difference between postmortem and antemortem free 
morphine concentration was 34.5 g/L (range -225 to +342) (P>0.05).  
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Discussion
Cook et al in 2000 published a study of six cases in which they measured antemortem and 
postmortem concentrations of seven different drugs.[20] They concluded that ‘A large degree 
of error can arise from attempting to estimate antemortem drug concentrations and the 
ingested dose from postmortem measurements.’ Tolliver et al came to similar conclusions 
from their study of seven subjects, in which the differences between morphine concentrations 
measured in antemortem and postmortem samples ranged from -100 g/L to +1400 g/L. 
Their study included subjects who had taken heroin; along with the heterogeneity of the 
postmortem samples, this hinders interpretation.. [21]. Almost all other studies compare 
average postmortem concentrations with average therapeutic antemortem concentrations. To 
our knowledge, the present study is the first to examine paired antemortem and postmortem 
samples for concentrations of morphine in therapeutic use.
Our subjects were generally older patients with multiple comorbidities including renal 
impairment: the mean eGFR was 47 mL/min/1.73 m2 (range 15 to 90 mL/min/1.73 m2). They 
had received different doses of morphine prior to their death via a variety of routes. There is 
no agreed therapeutic range for morphine, as the unconjugated and glucuronides  (M6G) 
morphine  can both have clinical  effects, and there is such a large variation in the 
pharmacokinetics and pharmacodynamics of pain relief. The antemortem total morphine 
concentrations in the samples we examined ranged from 5 g /L to 611 g/L. 
Our samples were taken sufficiently long after the last administration of morphine that 
absorption was likely to have been complete. We therefore predicted that, as a consequence 
of metabolism and elimination, the concentration at the point the patient died would be less 
than the concentration antemortem. The concentration of free morphine rose significantly 
from antemortem to postmortem sample (P < 0.01). The median change was 109% (range 0–
540%). The finding that the postmortem concentration of free morphine in all but one case 
exceeded the antemortem concentration was unexpected. One explanation is that free 
morphine may be generated after death by spontaneous hydrolysis of glucuronides in blood. 
Skopp and colleagues found that while morphine and its glucuronide metabolites are stable in 
blood and plasma at 4°C, this is not the case in postmortem whole blood. [22]. 
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There was no statistically significant difference overall between antemortem and postmortem 
total morphine concentration for our 11 patients, but the median value +56% with a range -
83% to +166%. The increases seen in this study are similarly mirrored in other studies. 
Hayward et al compared concentrations in two groups of patients, those with trauma and 
controls who were alive; and a further two groups in whom postmortem samples were 
obtained. [23]. In both trauma and non-trauma patients, average concentrations were higher 
in the samples taken from deceased individuals. 
As one of us has stated previously, “There is no reliable or obvious connection between 
concentrations measured in life and subsequent to death. Consequently concentrations 
measured after death cannot generally be interpreted to yield concentration present before 
death.” [12] Our study reiterates that message. 
Limitations
Ours is a comparatively small study of the relationship between morphine concentrations 
measured before and after death. Antemortem samples were taken some time after the last 
administration of morphine, but we cannot be sure in dying patients that they were all taken 
after the maximum concentration had been reached. We have not made pharmacokinetic 
calculations to extrapolate from the antemortem concentration at the time of sample to the 
concentration at the time the patient died; the applicable pharmacokinetic parameters are not 
known for the population we studied. Samples were taken at  postmortem, and the time from 
death to postmortem sampling was variable. The postmortem samples were taken from the 
femoral vein, and we had no comparative data from other sampling sites. We cannot therefore 
present the classic measures of postmortem redistribution such as central–peripheral 
ratio.[12] These, however, are proxy measures for the change that we examined directly. The 
antemortem samples were all serum samples, while the postmortem samples were clotted 
whole blood. However the overall difference between the two samples is probably small, as 
drug concentrations are measured in the chemically extracted “liquid” component. Total 
morphine concentration was measured by hydrolysis, so that it was not possible to measure 
individual glucuronide concentrations. These may have yielded more information on the 
changes we observed.
Conclusion
Page 5 of 9
URL: http://mc.manuscriptcentral.com/lclt E-mail: ICTX-peerreview@journals.tandf.co.uk
Clinical Toxicology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
It is important in determining cause of death to take into account the clinical features of the 
case, the inherent uncertainties in estimating antemortem concentrations from postmortem 
concentrations, and the possible competing causes of death. Our study demonstrates that there 
is a marked and significant increase in free morphine concentration after death, perhaps as a 
result of the hydrolysis of morphine glucuronides. While on average total morphine 
concentration taken from the same subject before and after death did not differ significantly, 
there was very marked variation among individuals. The postmortem morphine concentration 
found at autopsy may differ substantially from the antemortem morphine concentration. 
Therefore, the attribution of cause of death should take into account all the clinical 
circumstances, and should not be based solely on morphine concentrations determined after 
death.
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Free morphine concentration g/L Total morphine g/L
Case age sex eGFR morphine 
dose in 
24 hours 
before 
death 
(mg)
Interval 
from 
sample 
to 
death
Route AM PM Difference
PM - AM 
% change
after death 
AM PM Difference
PM - AM 
% change 
after death
1 88 f 49 48  sc 78 172 94 121 133 261 128 96
2 68 f 30 2.5 12 iv 5 29 24 480 18 41 23 128
3 72 f 19 5 18 po 5 5 0 0 14 12 -2 -14
4 73 m 49 24  sc 43 169 126 293 71 189 118 166
5 59 f 52 15 15 po 32 38 6 19 268 43 -225 -84
6 84 m 18 10 4 po 10 12 2 20 16 19 3 19
7 72 m 80 48  sc 27 111 84 311 238 171 -67 -28
8 56 f 90 140 12 po 40 41 1 3 240 221 -19 -7.9
9 49 m 29 48  sc 54 107 53 98 61 108 47 77
10 57 f 90 24  sc 5 32 27 540 5 36 31 620
11 37 m 15 72  sc NM NM -- -- 611 953 342 56
Median 68  49.0 24.0 12.0  29.5 39.5 25.5 109 71.0 108 23.0 32
Mean 65  47.4 39.7 12.2  29.9 71.6 41.7 188 152 186 34.5 23
Table 1 Patient characteristics and results for free and total antemortem and postmortem morphine concentrations
AM = antemortem, PM = postmortem, NM = not measured, m = male, f = female, sc = subcutaneous, po = oral, iv = intravenous
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